Abcam

NASDAQ: ABCM · Real-Time Price · USD
23.99
0.01 (0.04%)
At close: Dec 05, 2023, 9:00 PM

Company Description

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery.

Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools.

The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies.

It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific.

The company sells its products online.

Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Abcam
Abcam logo
Country GB
IPO Date Oct 22, 2020
Industry Biotechnology
Sector Healthcare
Employees 1,760
CEO Alan Thomas Hirzel BS, M.B.A., M.S.

Advertisement

Contact Details

Address:
Discovery Drive
Cambridge,
GB
Website https://www.abcam.com

Stock Details

Ticker Symbol ABCM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001492074
CUSIP Number 000380204
ISIN Number US0003802040
Employer ID 98-0487031
SIC Code 2836

Key Executives

Name Position
Alan Thomas Hirzel BS, M.B.A., M.S. Chief Executive Officer & Executive Director
Alan Thomas Hirzel BS, M.B.A., M.S., MBA, MS Chief Executive Officer & Executive Director
Mark Dermody Interim Chief Information Officer
Michael Shaun Baldock B.A. Chief Financial Officer & Director
Alejandra Solache Ph.D. Senior Vice President of Research & Development
Emma Sceats Senior Vice President of Sales & Marketing
Jac Price Senior Vice President of Manufacturing & Supply Chain
James Staveley Vice President of Investor Relations
John Baker Senior Vice President of Supply Chain & Manufacturing
Juan Carlos Sacristan Senior Vice President of Data & Digital
Kirstie Speck BBusSc Head of Consumer Insights
Marc Perkins Gen. Counsel & Company Sec.
Marc Leigh Russell Perkins General Counsel & Company Secretary
Mark Bushfield Senior Vice President of Research & Innovation
Nick Skinner Senior Vice President of Human Resources
Yvonne Chien Senior Vice President of Customer Experience

Latest SEC Filings

Date Type Title
Feb 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jan 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Dec 18, 2023 15-12G Filing
Dec 15, 2023 S-8 POS Filing
Dec 15, 2023 S-8 POS Filing
Dec 15, 2023 S-8 POS Filing
Dec 15, 2023 POSASR Filing
Dec 08, 2023 SC 13D/A [Amend] Filing
Dec 06, 2023 25-NSE Filing
Dec 06, 2023 6-K Filing